Intrinsic Value of S&P & Nasdaq Contact Us

Masimo Corporation MASI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
50/100
4/7 Pass
SharesGrow Intrinsic Value
$80.47
-54.9%
Analyst Price Target
$187.50
+5.1%

Masimo Corporation (MASI) generated $217.2M in operating cash flow for fiscal year 2025. After capital expenditures of $19.4M, free cash flow was $197.8M.

Free cash flow margin was 13% of revenue. Cash conversion ratio was -1.43x, suggesting some earnings are non-cash.

The company returned $363.7M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (83/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (74/100, Pass) — $197.8M (13% FCF margin) supports a durable competitive advantage
  • INCOME (10/100) — Cash conversion ratio was -1.43x suggests some earnings are non-cash items

Overall SharesGrow Score: 50/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
→ Valuation
FUTURE
61/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
74/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Masimo Corporation Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $217.8M$217.2M$196.4M$94.1M$29.5M
Capital Expenditure $-22M$-19.4M$-20M$-44M$-56.3M
Free Cash Flow $195.8M$197.8M$176.4M$6.4M$-26.8M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message